Global and China Non-Hodgkin Lymphoma Therapeutics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.3 Market by Application
1.3.1 Global Non-Hodgkin Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
1.3.2 Clinical Research
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Non-Hodgkin Lymphoma Therapeutics Market Perspective (2015-2026)
2.2 Global Non-Hodgkin Lymphoma Therapeutics Growth Trends by Regions
2.2.1 Non-Hodgkin Lymphoma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Non-Hodgkin Lymphoma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Non-Hodgkin Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Hodgkin Lymphoma Therapeutics Players by Market Size
3.1.1 Global Top Non-Hodgkin Lymphoma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Non-Hodgkin Lymphoma Therapeutics Revenue Market Share by Players (2015-2020)
3.2 Global Non-Hodgkin Lymphoma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Non-Hodgkin Lymphoma Therapeutics Revenue
3.4 Global Non-Hodgkin Lymphoma Therapeutics Market Concentration Ratio
3.4.1 Global Non-Hodgkin Lymphoma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Hodgkin Lymphoma Therapeutics Revenue in 2019
3.5 Key Players Non-Hodgkin Lymphoma Therapeutics Area Served
3.6 Key Players Non-Hodgkin Lymphoma Therapeutics Product Solution and Service
3.7 Date of Enter into Non-Hodgkin Lymphoma Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Hodgkin Lymphoma Therapeutics Breakdown Data by Type (2015-2026)
4.1 Global Non-Hodgkin Lymphoma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Non-Hodgkin Lymphoma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Non-Hodgkin Lymphoma Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Non-Hodgkin Lymphoma Therapeutics Historic Market Size by Application (2015-2020)
5.2 Global Non-Hodgkin Lymphoma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Non-Hodgkin Lymphoma Therapeutics Market Size (2015-2026)
6.2 North America Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020)
6.3 North America Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020)
6.4 North America Non-Hodgkin Lymphoma Therapeutics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Non-Hodgkin Lymphoma Therapeutics Market Size (2015-2026)
7.2 Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020)
7.3 Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020)
7.4 Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Non-Hodgkin Lymphoma Therapeutics Market Size (2015-2026)
8.2 China Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020)
8.3 China Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020)
8.4 China Non-Hodgkin Lymphoma Therapeutics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Non-Hodgkin Lymphoma Therapeutics Market Size (2015-2026)
9.2 Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020)
9.3 Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020)
9.4 Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size (2015-2026)
10.2 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020)
10.3 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020)
10.4 Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Company Details
11.1.2 Bristol Myers Squibb Business Overview
11.1.3 Bristol Myers Squibb Non-Hodgkin Lymphoma Therapeutics Introduction
11.1.4 Bristol Myers Squibb Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020))
11.1.5 Bristol Myers Squibb Recent Development
11.2 Celgene
11.2.1 Celgene Company Details
11.2.2 Celgene Business Overview
11.2.3 Celgene Non-Hodgkin Lymphoma Therapeutics Introduction
11.2.4 Celgene Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.2.5 Celgene Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Details
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Non-Hodgkin Lymphoma Therapeutics Introduction
11.3.4 Eli Lilly Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.3.5 Eli Lilly Recent Development
11.4 F. Hoffman La-Roche
11.4.1 F. Hoffman La-Roche Company Details
11.4.2 F. Hoffman La-Roche Business Overview
11.4.3 F. Hoffman La-Roche Non-Hodgkin Lymphoma Therapeutics Introduction
11.4.4 F. Hoffman La-Roche Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.4.5 F. Hoffman La-Roche Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Non-Hodgkin Lymphoma Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.5.5 GlaxoSmithKline Recent Development
11.6 Accredo Health Group
11.6.1 Accredo Health Group Company Details
11.6.2 Accredo Health Group Business Overview
11.6.3 Accredo Health Group Non-Hodgkin Lymphoma Therapeutics Introduction
11.6.4 Accredo Health Group Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.6.5 Accredo Health Group Recent Development
11.7 Baxter International
11.7.1 Baxter International Company Details
11.7.2 Baxter International Business Overview
11.7.3 Baxter International Non-Hodgkin Lymphoma Therapeutics Introduction
11.7.4 Baxter International Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.7.5 Baxter International Recent Development
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Non-Hodgkin Lymphoma Therapeutics Introduction
11.8.4 Bayer Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.8.5 Bayer Recent Development
11.9 Cephalon
11.9.1 Cephalon Company Details
11.9.2 Cephalon Business Overview
11.9.3 Cephalon Non-Hodgkin Lymphoma Therapeutics Introduction
11.9.4 Cephalon Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.9.5 Cephalon Recent Development
11.10 Eisai Pharmaceuticals
11.10.1 Eisai Pharmaceuticals Company Details
11.10.2 Eisai Pharmaceuticals Business Overview
11.10.3 Eisai Pharmaceuticals Non-Hodgkin Lymphoma Therapeutics Introduction
11.10.4 Eisai Pharmaceuticals Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
11.10.5 Eisai Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Global Non-Hodgkin Lymphoma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Non-Hodgkin Lymphoma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Non-Hodgkin Lymphoma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions (2015-2020)
Table 9. Global Non-Hodgkin Lymphoma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions (2021-2026)
Table 11. Non-Hodgkin Lymphoma Therapeutics Market Market Trends
Table 12. Non-Hodgkin Lymphoma Therapeutics Market Drivers
Table 13. Non-Hodgkin Lymphoma Therapeutics Market Challenges
Table 14. Non-Hodgkin Lymphoma Therapeutics Market Restraints
Table 15. Global Non-Hodgkin Lymphoma Therapeutics Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Players (2015-2020)
Table 17. Global Top Non-Hodgkin Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hodgkin Lymphoma Therapeutics as of 2019)
Table 18. Global Non-Hodgkin Lymphoma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-Hodgkin Lymphoma Therapeutics Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Type (2015-2020)
Table 24. Global Non-Hodgkin Lymphoma Therapeutics Revenue Market Share by Type (2021-2026)
Table 25. Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Application (2015-2020)
Table 26. Global Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Non-Hodgkin Lymphoma Therapeutics Market Size Share by Application (2021-2026)
Table 28. North America Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 30. North America Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 32. North America Non-Hodgkin Lymphoma Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Non-Hodgkin Lymphoma Therapeutics Market Share by Country (2015-2020)
Table 34. Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 36. Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Non-Hodgkin Lymphoma Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Non-Hodgkin Lymphoma Therapeutics Market Share by Country (2015-2020)
Table 40. China Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 41. China Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 42. China Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 43. China Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 44. China Non-Hodgkin Lymphoma Therapeutics Market Size by Region (US$ Million) (2015-2020)
Table 45. China Non-Hodgkin Lymphoma Therapeutics Market Share by Region (2015-2020)
Table 46. Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 48. Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Non-Hodgkin Lymphoma Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Non-Hodgkin Lymphoma Therapeutics Market Share by Country (2015-2020)
Table 52. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Share by Type (2015-2020)
Table 54. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Share by Country (2015-2020)
Table 58. Bristol Myers Squibb Company Details
Table 59. Bristol Myers Squibb Business Overview
Table 60. Bristol Myers Squibb Product
Table 61. Bristol Myers Squibb Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 62. Bristol Myers Squibb Recent Development
Table 63. Celgene Company Details
Table 64. Celgene Business Overview
Table 65. Celgene Product
Table 66. Celgene Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 67. Celgene Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Product
Table 71. Eli Lilly Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. F. Hoffman La-Roche Company Details
Table 74. F. Hoffman La-Roche Business Overview
Table 75. F. Hoffman La-Roche Product
Table 76. F. Hoffman La-Roche Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 77. F. Hoffman La-Roche Recent Development
Table 78. GlaxoSmithKline Company Details
Table 79. GlaxoSmithKline Business Overview
Table 80. GlaxoSmithKline Product
Table 81. GlaxoSmithKline Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 82. GlaxoSmithKline Recent Development
Table 83. Accredo Health Group Company Details
Table 84. Accredo Health Group Business Overview
Table 85. Accredo Health Group Product
Table 86. Accredo Health Group Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 87. Accredo Health Group Recent Development
Table 88. Baxter International Company Details
Table 89. Baxter International Business Overview
Table 90. Baxter International Product
Table 91. Baxter International Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 92. Baxter International Recent Development
Table 93. Bayer Business Overview
Table 94. Bayer Product
Table 95. Bayer Company Details
Table 96. Bayer Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 97. Bayer Recent Development
Table 98. Cephalon Company Details
Table 99. Cephalon Business Overview
Table 100. Cephalon Product
Table 101. Cephalon Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 102. Cephalon Recent Development
Table 103. Eisai Pharmaceuticals Company Details
Table 104. Eisai Pharmaceuticals Business Overview
Table 105. Eisai Pharmaceuticals Product
Table 106. Eisai Pharmaceuticals Revenue in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020) (US$ Million)
Table 107. Eisai Pharmaceuticals Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Clinical Research Case Studies
Figure 6. Treatment Case Studies
Figure 7. Non-Hodgkin Lymphoma Therapeutics Report Years Considered
Figure 8. Global Non-Hodgkin Lymphoma Therapeutics Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Regions (2021-2026)
Figure 11. Global Non-Hodgkin Lymphoma Therapeutics Market Share by Players in 2019
Figure 12. Global Top Non-Hodgkin Lymphoma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-Hodgkin Lymphoma Therapeutics as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Non-Hodgkin Lymphoma Therapeutics Revenue in 2019
Figure 14. North America Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa Non-Hodgkin Lymphoma Therapeutics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Bristol Myers Squibb Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 42. Celgene Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 43. Eli Lilly Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 44. F. Hoffman La-Roche Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 46. Accredo Health Group Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 47. Baxter International Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 48. Bayer Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 49. Cephalon Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 50. Eisai Pharmaceuticals Revenue Growth Rate in Non-Hodgkin Lymphoma Therapeutics Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed